Synedica CagriReta is a dual-pen research formulation containing two separate peptide preparations: 4mg Cagrilintide and 40mg Retatrutide.

According to the product packaging, the kit contains:

• 1 pen containing 4mg Cagrilintide
• 1 pen containing 40mg Retatrutide
• 12 disposable needles
• 1 instruction book

The packaging identifies the product as a Cagrilintide & Retatrutide Dual Pen Kit and indicates a once-weekly format.

Cagrilintide and retatrutide are investigated independently in scientific research involving metabolic and appetite-related pathways. This combined product is supplied as two separate pens rather than a single combined formulation.

Key Features

• Synedica dual-peptide research kit
• 4mg Cagrilintide pen
• 40mg Retatrutide pen
• Two separate prefilled pens
• 12 disposable needles included
• Instruction book included
• Convenient dual-pen format
• Intended for laboratory research

How to Use (Research Reference Only)

This product is intended exclusively for laboratory and scientific research conducted by qualified professionals following established research protocols.

No human-use dosing instructions are provided.

Not intended for human consumption.

Research Applications

Cagrilintide and retatrutide may be investigated separately in laboratory research involving:

• Metabolic signalling
• Appetite-related pathways
• Energy-balance research
• Peptide receptor studies
• Glucose and metabolic pathway research
• Body-composition research

Research Disclaimer ( Synedica CagriReta )

For laboratory and scientific research use only.

Not intended for human consumption, therapeutic use, diagnosis, or medical application.